← Open Payments lookup

RACHEL LITTERER: Open Payments

NPI 1740500214 · HORN LAKE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,336 in 75 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $1,336

Food & beverage: $1,336
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$210
Bayer Healthcare Pharmaceuticals Inc.8$175
Amgen Inc.12$137
Sumitomo Pharma America, Inc.6$116
ABBVIE INC.5$109
Novo Nordisk Inc6$103
Lilly USA, LLC6$95
Esperion Therapeutics, Inc.3$61
IBSA Pharma Inc.3$50
Dexcom, Inc.2$49

Products named: FARXIGA, Kerendia, GEMTESA, UBRELVY, OTEZLA, NEXLETOL, REPATHA, Ozempic.

Industry payments across MS — which companies pay providers there.